Shanghai HeartCare Medical Technology Past Earnings Performance
Past criteria checks 2/6
Shanghai HeartCare Medical Technology has been growing earnings at an average annual rate of 44.2%, while the Medical Equipment industry saw earnings growing at 14.9% annually. Revenues have been growing at an average rate of 24.4% per year. Shanghai HeartCare Medical Technology's return on equity is 3.8%, and it has net margins of 12.7%.
Key information
44.16%
Earnings growth rate
53.26%
EPS growth rate
| Medical Equipment Industry Growth | 13.68% |
| Revenue growth rate | 24.38% |
| Return on equity | 3.81% |
| Net Margin | 12.67% |
| Last Earnings Update | 30 Jun 2025 |
Recent past performance updates
Recent updates
Some Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609) Shareholders Look For Exit As Shares Take 29% Pounding
Nov 04
Investors Shouldn't Be Too Comfortable With Shanghai HeartCare Medical Technology's (HKG:6609) Earnings
Sep 30A Piece Of The Puzzle Missing From Shanghai HeartCare Medical Technology Corporation Limited's (HKG:6609) 27% Share Price Climb
Aug 18Shanghai HeartCare Medical Technology Corporation Limited's (HKG:6609) Shares Leap 29% Yet They're Still Not Telling The Full Story
Jul 03We Think Shareholders Are Less Likely To Approve A Pay Rise For Shanghai HeartCare Medical Technology Corporation Limited's (HKG:6609) CEO For Now
May 19Shanghai HeartCare Medical Technology Corporation Limited's (HKG:6609) 32% Share Price Surge Not Quite Adding Up
Feb 10Even With A 42% Surge, Cautious Investors Are Not Rewarding Shanghai HeartCare Medical Technology Corporation Limited's (HKG:6609) Performance Completely
Sep 27Some Shareholders Feeling Restless Over Shanghai HeartCare Medical Technology Corporation Limited's (HKG:6609) P/S Ratio
Aug 01We're Not Very Worried About Shanghai HeartCare Medical Technology's (HKG:6609) Cash Burn Rate
Jan 23Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely
Aug 30Companies Like Shanghai HeartCare Medical Technology (HKG:6609) Are In A Position To Invest In Growth
Aug 09Companies Like Shanghai HeartCare Medical Technology (HKG:6609) Are In A Position To Invest In Growth
May 07We're Hopeful That Shanghai HeartCare Medical Technology (HKG:6609) Will Use Its Cash Wisely
Nov 29Revenue & Expenses Breakdown
How Shanghai HeartCare Medical Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 25 | 335 | 42 | 149 | 48 |
| 31 Mar 25 | 306 | 14 | 143 | 53 |
| 31 Dec 24 | 278 | -14 | 138 | 59 |
| 30 Sep 24 | 265 | -29 | 139 | 72 |
| 30 Jun 24 | 251 | -45 | 140 | 86 |
| 31 Mar 24 | 242 | -69 | 147 | 105 |
| 31 Dec 23 | 232 | -94 | 154 | 124 |
| 30 Sep 23 | 224 | -141 | 160 | 143 |
| 30 Jun 23 | 216 | -188 | 165 | 163 |
| 31 Mar 23 | 199 | -194 | 167 | 158 |
| 31 Dec 22 | 183 | -200 | 168 | 154 |
| 30 Sep 22 | 160 | -185 | 155 | 129 |
| 30 Jun 22 | 137 | -169 | 142 | 105 |
| 31 Mar 22 | 115 | -188 | 146 | 92 |
| 31 Dec 21 | 90 | -194 | 135 | 76 |
| 30 Sep 21 | 66 | -242 | 176 | 75 |
| 30 Jun 21 | 43 | -290 | 217 | 73 |
| 31 Mar 21 | 28 | -244 | 179 | 60 |
| 31 Dec 20 | 15 | -214 | 156 | 51 |
Quality Earnings: 6609 has a large one-off gain of CN¥22.5M impacting its last 12 months of financial results to 30th June, 2025.
Growing Profit Margin: 6609 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 6609 has become profitable over the past 5 years, growing earnings by 44.2% per year.
Accelerating Growth: 6609 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 6609 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (14.7%).
Return on Equity
High ROE: 6609's Return on Equity (3.8%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/04 23:14 |
| End of Day Share Price | 2025/12/04 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shanghai HeartCare Medical Technology Corporation Limited is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jin Zhang | China International Capital Corporation Limited |
| null null | China International Capital Corporation Limited |
| Yuan Gao | China International Capital Corporation Limited |